6,7-DIFLUORO-3-((4S)-4-METHYL-2-OXO-3-OXAZOLIDINYL)-1,2-BENZISOXAZOLE-5-CARBOXALDEHYDE
UNII Q45PUH2HK2
Substance Identification & Data
This profile provides standardized clinical and technical data for 6,7-difluoro-3-((4s)-4-methyl-2-oxo-3-oxazolidinyl)-1,2-benzisoxazole-5-carboxaldehyde, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q45PUH2HK2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1802089-88-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C12H8F2N2O4 WWZLVEIBRFLUKZ-YFKPBYRVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6,7-difluoro-3-((4s)-4-methyl-2-oxo-3-oxazolidinyl)-1,2-benzisoxazole-5-carboxaldehyde. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.